Ownership history in UBS Group AG · 6 quarters on record
This page tracks every 13F SEC filing in which UBS Group AG reported a position in VIVOS THERAPEUTICS INC (VVOS). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.
| Quarter | Action | Shares | Change | Chg % | % of Fund | Mkt Value | Price (EOQ) |
|---|---|---|---|---|---|---|---|
| 2025 Q4 | ADDED | 12,677 | +12,575 | +12328.4% | 0.00% | $26K | $2.03 |
| 2025 Q3 | REDUCED | 102 | -142,699 | -99.9% | 0.00% | $316 | $3.10 |
| 2025 Q2 | ADDED | 142,801 | +140,922 | +7499.8% | 0.00% | $451K | $3.16 |
| 2025 Q1 | ADDED | 1,879 | +1,490 | +383.0% | 0.00% | $5K | $2.85 |
| 2024 Q4 | ADDED | 389 | +311 | +398.7% | 0.00% | $2K | $4.29 |
| 2024 Q3 | INITIATED | 78 | — | — | 0.00% | $204 | $2.61 |
As of 2025 Q4 — sorted by position size